These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3495811)
21. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Banki CM; Karmacsi L; Bissette G; Nemeroff CB Eur Neuropsychopharmacol; 1992 Jun; 2(2):107-13. PubMed ID: 1352999 [TBL] [Abstract][Full Text] [Related]
22. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. De Bellis MD; Gold PW; Geracioti TD; Listwak SJ; Kling MA Am J Psychiatry; 1993 Apr; 150(4):656-7. PubMed ID: 8465888 [TBL] [Abstract][Full Text] [Related]
24. Catecholamines in depression: a cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH. Grossman F; Potter WZ Psychiatry Res; 1999 Jul; 87(1):21-7. PubMed ID: 10512151 [TBL] [Abstract][Full Text] [Related]
25. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion. Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579 [TBL] [Abstract][Full Text] [Related]
26. Indices of noradrenergic output in depression. Siever LJ; Uhde TW; Jimerson DC; Lake CR; Kopin IJ; Murphy DL Psychiatry Res; 1986 Sep; 19(1):59-73. PubMed ID: 3786600 [TBL] [Abstract][Full Text] [Related]
27. Suicidal behavior in depression: relationship to noradrenergic function. Roy A; Pickar D; De Jong J; Karoum F; Linnoila M Biol Psychiatry; 1989 Feb; 25(3):341-50. PubMed ID: 2914156 [TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers. Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048 [TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid neuropeptides in mood disorder and dementia. Banki CM; Karmacsi L; Bissette G; Nemeroff CB J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520 [TBL] [Abstract][Full Text] [Related]
30. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830 [TBL] [Abstract][Full Text] [Related]
31. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802 [TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928 [No Abstract] [Full Text] [Related]
33. Urinary-free cortisol in depressed patients and controls: relationship to urinary indices of noradrenergic function. Roy A; Linnoila M; Karoum F; Pickar D Psychol Med; 1988 Feb; 18(1):93-8. PubMed ID: 3363046 [TBL] [Abstract][Full Text] [Related]
34. Pre-menopausal and post-menopausal depressed women. Roy A; Linnoila M; Jimerson DC; Gold P; Pickar D Aust N Z J Psychiatry; 1986 Dec; 20(4):464-9. PubMed ID: 3494443 [TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445 [TBL] [Abstract][Full Text] [Related]
38. No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by cortisol administration. Kellner M; Salzwedel C; Wortmann V; Urbanowicz T; Boelmans K; Yassouridis A; Stalla GK; Wiedemann K Psychiatry Res; 2013 Dec; 210(2):662-4. PubMed ID: 23896353 [TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism. Roy A; DeJong J; Gold P; Rubinow D; Adinoff B; Ravitz B; Waxman R; Linnoila M Acta Psychiatr Scand; 1990 Jul; 82(1):44-8. PubMed ID: 1975969 [TBL] [Abstract][Full Text] [Related]
40. Extraversion in pathological gamblers. Correlates with indexes of noradrenergic function. Roy A; De Jong J; Linnoila M Arch Gen Psychiatry; 1989 Aug; 46(8):679-81. PubMed ID: 2751401 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]